Day: July 31, 2025

Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, July 31, 2025 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB) (the “Company”),  a clinical-stage inflammation and immunology company, today announced that it will host a conference call on Thursday, August 7th, 2025 at 4:30pm EDT to discuss results for its quarter ended June 30, 2025 and to provide a corporate update.  Conference Call Information To participate in this event, dial approximately 5 to 10 minutes before the beginning of the call. Please ask for the INmune Bio First Quarter Conference Call when reaching the operator. Date: August 7th, 2025 Time: 4:30 PM Eastern Time Participant Dial-in: 1-800-225-9448 Participant Dial-in (international): +1-203-518-9783 Conference ID: INMUNE A live audio webcast of the call can be accessed...

Company reports Diluted EPS of $2.80, Economic EPS of $5.39 in the second quarter of 2025Positive net client cash flows of more than $8 billion, driven by ongoing momentum in private markets and liquid alternatives  New partnership with Montefiore Investment further diversifies AMG’s business and expands its participation in private markets Economic Earnings per share of $5.39 for the quarter, an increase of 15% relative to prior-year quarter Repurchased ~$100 million in common stock, bringing total share repurchases to ~$273 million in the first half of the yearWEST PALM BEACH, Fla., July 31, 2025 (GLOBE NEWSWIRE) — AMG, a strategic partner to leading independent investment management firms globally, today reported its financial and operating results for the second quarter and six months ended June 30, 2025. Jay C. Horgen,...

Company delivers record second quarter revenue, meets or exceeds all guidance metrics Reiterates full year 2025 key guidance on strength in consumer demand MIAMI, July 31, 2025 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd. (“NCLC”), “Norwegian Cruise Line Holdings”, “Norwegian”, “NCLH” or the “Company”) today reported financial results for the second quarter ended June 30, 2025 and provided guidance for the third quarter and full year 2025. HighlightsGenerated record total revenue for second quarter of $2.5 billion, an increase of 6% versus second quarter of 2024. GAAP net income was $30.0 million, with EPS of $0.07. Delivered Adjusted EBITDA1 of $694 million, exceeding guidance. Adjusted EPS1 was $0.51, meeting guidance, despite an $0.082 impact from foreign exchange. Reaffirmed...

Solid execution and asset performance support higher 2025 financial outlook Market fundamentals drive customer demand for incremental capacity projects CALGARY, Alberta, July 31, 2025 (GLOBE NEWSWIRE) — TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) released its second quarter results today. François Poirier, TC Energy’s President and Chief Executive Officer commented, “Our commitment to safety and operational excellence continues to drive strong reliability, availability and financial performance, and we now expect our 2025 comparable EBITDA1 outlook to be higher, in the range of $10.8 to $11.0 billion.” Poirier continued, “Compelling fundamentals are unlocking further growth opportunities across our North American portfolio. To meet this unprecedented demand, we have announced $4.5 billion of new growth...

$12.5 million in second quarter PYRUKYND® (mitapivat) net revenues; ended second quarter with $1.3 billion dollars in cash, cash equivalents and marketable securities PYRUKYND sNDA for thalassemia under active review, with FDA PDUFA goal date of September 7, 2025 Topline results from RISE UP Phase 3 trial of mitapivat in sickle cell disease on track by year-end with potential U.S. commercial launch in 2026 Dosed first patient in the tebapivat Phase 2 sickle cell disease trial and received IND clearance for AG-236CAMBRIDGE, Mass., July 31, 2025 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced financial results and updates for the second quarter ended June 30, 2025. “With fewer...

Second quarter revenues totaled $2.0 billion, including $590 million Services contribution, reflecting an 8% decline and 16% increase respectively year-over-year; Corporation delivered 36 aircraft for the quarter. Adjusted EBITDA(1) totaled $297 million and reported EBIT was $205 million for the quarter, down 11% and up 7% year-over-year respectively. Net income(2) and adjusted net income(1) were $193 million and $117 million, respectively, up $174 million and $6 million compared to the second quarter of 2024. Diluted EPS(2) reached $1.87, while adjusted EPS(3) was at $1.11. Free cash flow usage(1) came in at $164 million, compared to $68 million free cash flow usage(1) for the same quarter of 2024, due primarily to planned inventory build for higher second half output; cash flow usage from operating activities(2) and net additions to...

WAYNE, Pa., July 31, 2025 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the second quarter ended June 29, 2025. Second quarter financial summaryGAAP revenue of $780.9, up 4.2% compared to the prior year period; up 1.0% on an adjusted constant currency basis   GAAP diluted EPS from continuing operations of $2.77, compared to $1.69 in the prior year period  Adjusted diluted EPS from continuing operations of $3.73, compared to $3.42 in the prior year period2025 guidance summary (inclusive of the recently closed BIOTRONIK Vascular Intervention business)Raising GAAP revenue growth guidance range to 9.00% to 10.00% Raising adjusted constant currency revenue growth guidance range to 7.70% to 8.70%  Raising GAAP EPS from continuing operations guidance range to $6.73 to...

– Increases 2025 Outlook on Solid Growth in Net Income and FFO – – Same Property NOI Increased 3.1% – – Small Shop Occupancy Reaches Record High – JERICHO, N.Y., July 31, 2025 (GLOBE NEWSWIRE) — Kimco Realty® (NYSE: KIM), a real estate investment trust (REIT) and leading owner and operator of high-quality, open-air, grocery-anchored shopping centers and mixed-use properties in the United States, today reported results for the second quarter ended June 30, 2025. For the three months ended June 30, 2025 and 2024, Net income available to the company’s common shareholders (“Net income”) per diluted share was $0.23 and $0.17, respectively. HighlightsReported 7.3% growth in Funds From Operations* (“FFO”) per diluted share over the same period in 2024 to $0.44. Produced a 3.1% increase in Same Property Net Operating Income* (“NOI”)...